Sermorelin 2000 mcg (2 mg) is a synthetic 29-amino-acid polypeptide representing the biologically active N-terminal sequence of endogenous growth hormone-releasing hormone (GHRH 1-29 amide). In laboratory settings, it serves as a baseline reference agonist for evaluating GHRH receptor signal transduction, somatotroph responsiveness, and downstream physiological cascades. PX1 Research supplies high-purity, USA-manufactured Sermorelin for in vitro and preclinical investigation.
Sermorelin 2000 mcg (2 mg) is a synthetic 29-amino-acid polypeptide representing the biologically active N-terminal sequence of endogenous growth hormone-releasing hormone (GHRH 1-29 amide). In laboratory settings, it serves as a baseline reference agonist for evaluating GHRH receptor signal transduction, somatotroph responsiveness, and downstream physiological cascades. PX1 Research supplies high-purity, USA-manufactured Sermorelin for in vitro and preclinical investigation.
Sermorelin 2000 mcg (equivalent to 2 mg) is a synthesized peptide sequence corresponding to the minimal fully functional fragment of human growth hormone-releasing hormone. Comprising amino acids 1 through 29 of the native 44-amino-acid parent peptide, this truncated analog retains complete binding affinity for the growth hormone-releasing hormone receptor (GHRH-R) located on anterior pituitary somatotrophs.
In experimental research, a 2000 mcg mass represents a standardized analytical quantity utilized for preparing high-concentration stock solutions, high-throughput screening assays, and comparative bio-activity studies. The compound is supplied as a sterile, lyophilized cake designed exclusively for reconstitution within laboratory protocols. Researchers utilize Sermorelin to isolate GHRH-R activation dynamics without the biological interference of full-length GHRH accessory domain degradation products.
When sourcing reagents for cellular or animal models, selecting verified analytical-grade material ensures that experimental outcomes remain unconfounded by synthesis impurities or residual trifluoroacetate (TFA) salts. Researchers can access PX1 Research's catalog of verified research compounds to support standardized baseline methodologies.
The molecular architecture of Sermorelin acetate consists of the sequence Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2. With an approximate molecular mass of 3357.9 Da, this primary sequence encompasses the essential residues required for GHRH receptor binding, G-protein activation, and intracellular signal initiation.
Structural characterization demonstrates that the N-terminal Tyr1 residue is paramount for binding affinity and catalytic activation of the classical adenylate cyclase pathway. Modifications or enzymatically driven cleavage at this position rapidly abolish biological action. Preclinical binding studies indicate that Sermorelin exhibits sub-nanomolar affinity (Ki ~0.2–1.5 nM) for human and rodent GHRH receptors, matching or exceeding the baseline agonist activity of full-length endogenous GHRH(1-44).
Because of its reduced peptide chain length relative to native GHRH, Sermorelin presents a favorable profile for chemical synthesis precision. The reduction in complex secondary folding artifacts minimizes peptide aggregation during high-volume synthesis, permitting high purity yields when purified via reverse-phase high-performance liquid chromatography (RP-HPLC).
At the cellular level, Sermorelin operates via selective binding to the GHRH receptor, a seven-transmembrane domain Class B G-protein coupled receptor (GPCR) predominantly expressed on the cell surface of anterior pituitary somatotrophs. Ligand engagement triggers a conformational shift that stimulates the stimulatory G-protein subunit (Gs alpha).
Activation of Gs alpha directly stimulates membrane-bound adenylyl cyclase, driving the intracellular conversion of adenosine triphosphate (ATP) to cyclic adenosine monophosphate (cAMP). Elevated cAMP levels activate Protein Kinase A (PKA), which subsequently phosphorylates specific transcription factors, notably the cAMP response element-binding protein (CREB). PKA and CREB signaling promote the transcriptional upregulation of the growth hormone (GH1) gene.
Concurrently, PKA activation leads to the opening of voltage-gated L-type calcium channels, inducing an influx of extracellular calcium (Ca2+). Elevated intracellular calcium sparks exocytosis of pre-stored growth hormone secretory granules into the extracellular medium. In vitro and animal models demonstrate that this cascade maintains intact negative feedback sensitivity via somatostatin (SRIF) receptors, causing growth hormone release under Sermorelin stimulation to remain pulsatile rather than tonic.
Evaluating secretagogues requires distinguishing between true GHRH receptor agonists and growth hormone secretagogue receptor (GHSR-1a) agonists. Sermorelin belongs strictly to the former category, exhibiting high specificity for GHRH-R without cross-reacting with ghrelin receptors.
When designed into experimental models, researchers frequently compare Sermorelin against modified GHRH variants such as CJC-1295 No DAC and Tesamorelin 2mg. While Sermorelin represents the native 1-29 amino acid sequence with a rapid clearance half-life in physiological media (~8–12 minutes), CJC-1295 contains specific amino acid substitutions (e.g., D-Ala2, Gln8, Ala15, Leu27) engineered to resist enzymatic cleavage by dipeptidyl peptidase IV (DPP-IV). Tesamorelin incorporates a trans-3-hexenoic acid group at the N-terminus to elevate plasma stability while maintaining native GHRH receptor selectivity.
In contrast, compounds such as Ipamorelin 5mg operate through entirely distinct signaling pathways by targeting the GHSR-1a receptor. Dual-agonist research protocols frequently investigate the synergistic amplification of growth hormone expression when a GHRH agonist like Sermorelin 2000 mcg is co-incubated with a selective ghrelin mimetic. Detailed comparative literature and structural taxonomies are available via the PX1 research peptides hub.
In animal model systems, Sermorelin has been extensively studied to characterize the mechanics of the hypothalamic-pituitary-somatotropic axis. Rodent studies demonstrate that continuous or intermittent administration of GHRH(1-29) NH2 promotes somatotroph cell hyperplasia and preserves anterior pituitary secretory function in models of pituitary blunting or age-associated somatopause.
Beyond classical endocrine pathways, in vitro assays utilize Sermorelin to investigate non-endocrine GHRH receptor signaling in non-pituitary tissue types. GHRH-R expression has been identified in cardiac myocytes, endothelial cells, pulmonary tissue, and specific tumor cell lines. In preclinical cardiovascular models, GHRH agonist exposure has been shown to reduce post-infarction remodeling, attenuate cardiomyocyte apoptosis, and enhance tissue repair via calcineurin- and ERK1/2-dependent signaling.
Additionally, rodent models focusing on sleep architecture and neuroendocrine control demonstrate that central and peripheral GHRH-R activation influences non-rapid eye movement (NREM) sleep regulation. These preclinical observations reinforce Sermorelin's utility as a baseline assay reagent for cellular bioenergetics and receptor cross-talk studies.
To preserve structural integrity during laboratory handling, Sermorelin 2000 mcg must be reconstituted using precise aseptic techniques. For standard analytical or cell culture applications, standard laboratory diluents such as sterile 0.9% sodium chloride, bacteriostatic water containing 0.9% benzyl alcohol, or cell-culture grade phosphate-buffered saline (PBS) are typically employed.
To achieve a standard target concentration of 1000 mcg/mL (1 mg/mL) from a 2000 mcg vial, precisely 2.0 mL of diluent should be introduced using a sterile syringe. Alternatively, adding 1.0 mL of diluent yields a higher working stock concentration of 2000 mcg/mL (2 mg/mL). The diluent should be directed gently down the interior glass wall of the vial rather than sprayed directly onto the lyophilized cake to avoid shear stress and peptide denaturation.
Gentle rotational agitation should be applied until complete dissolution occurs. Vortexing or violent shaking must be strictly avoided, as mechanical agitation promotes the formation of hydrophobic aggregates and soluble fibrils. All reconstituted solutions should be evaluated visually for clarity, complete solubility, and freedom from particulate matter prior to assay introduction.
Unreconstituted, lyophilized Sermorelin 2000 mcg remains highly stable when stored in sub-zero environments. For long-term preservation (up to 24 months), lyophilized vials must be maintained at -20°C or -80°C in a desiccated environment protected from direct light exposure. Short-term storage of the dry powder at room temperature (15°C to 25°C) should not exceed 3 to 4 weeks.
Once reconstituted into aqueous solution, the chemical stability of Sermorelin decreases significantly due to susceptibility to hydrolysis, oxidation (specifically at the Met27 residue), and enzymatic degradation. Reconstituted stock solutions prepared with bacteriostatic water may be held under refrigeration (2°C to 8°C) for up to 28 days. Solutions prepared in non-preserved sterile saline or buffer solutions must be utilized immediately or aliquoted.
To prevent loss of biological activity from repeated freeze-thaw cycles, reconstituted working stock should be divided into single-use microcentrifuge aliquots using low-protein-binding polypropylene tubes and immediately stored at -80°C. Repeated temperature fluctuations induce physical degradation and irreversible aggregation of the 29-amino-acid chain.
Reliable scientific outcomes require verified purity metrics. Standard laboratory validation of Sermorelin 2000 mcg relies on two core analytical methodologies: Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS).
RP-HPLC assesses chemical purity by separating the primary Sermorelin peak from synthesis byproducts, truncated fragments, and protecting-group remnants. PX1 Research mandates that every lot exhibit a minimum chromatographic purity of 98.0% via HPLC integration at 214 nm. Mass spectrometry confirms exact identity, verifying that the observed molecular weight matches the theoretical monoisotopic or average mass of 3357.9 Da within strict error tolerances.
In addition to purity and mass verification, endotoxin testing via Chromogenic Limulus Amebocyte Lysate (LAL) assays is mandatory for cell culture and preclinical animal models. Bacterial endotoxins (lipopolysaccharides) alter cell viability and induce non-specific inflammatory signaling pathways. Every lot of Sermorelin 2mg supplied by PX1 Research undergoes strict LAL testing to ensure endotoxin levels remain well below standard analytical thresholds (<0.05 EU/mg).
Selecting a high-tier reagent supplier is critical to ensuring consistent, reproducible laboratory results across multi-phase experimental trials. Low-grade synthesis reagents often introduce batch-to-batch variability, residual heavy metals, TFA contamination, and uncharacterized organic impurities that compromise metabolic and binding assays.
PX1 Research maintains rigorous quality control frameworks by manufacturing compounds in USA-based, GMP-compliant facilities operating under ISO 17025 accredited analytical standards. Every lot of Sermorelin 2000 mcg is assigned a unique lot number linked to an accessible, third-party Certificate of Analysis (COA) detailing HPLC chromatograms, mass spectra, and endotoxin quantitation.
Researchers managing high-volume screening operations or institutional grant budgets can access specialized procurement programs through our wholesale lab portal. All orders ship directly from centralized facilities in California and Arizona, providing same-day dispatch for orders finalized before standard cutoff windows to ensure uninterrupted cold-chain logistics.
What is the physical quantity represented by Sermorelin 2000 mcg?
Sermorelin 2000 mcg represents 2.0 milligrams (mg) of net lyophilized peptide powder. This mass is calibrated for laboratory reconstitution to prepare standard working stock concentrations for in vitro and preclinical research applications.
How does Sermorelin compare in length and activity to native GHRH?
Native endogenous GHRH consists of 44 amino acids. Sermorelin comprises the first 29 amino acids (GHRH 1-29 amide). Preclinical literature establishes that this truncated sequence retains full receptor binding affinity and biological activity comparable to the full-length hormone.
What diluent should be used to reconstitute Sermorelin 2000 mcg for lab use?
Depending on assay requirements, standard laboratory diluents include sterile bacteriostatic water (containing 0.9% benzyl alcohol) for multi-use refrigerated stocks, or sterile 0.9% sodium chloride / PBS for immediate single-use in vitro cell culture assays.
How should reconstituted Sermorelin stock solutions be stored?
Reconstituted solutions in bacteriostatic water should be refrigerated at 2°C to 8°C for up to 28 days. For extended storage, solutions should be divided into single-use microcentrifuge aliquots and kept at -80°C to prevent freeze-thaw degradation.
What purity level is required for Sermorelin used in baseline assays?
Analytical and cellular research requires a minimum purity of 98.0% verified by RP-HPLC. Lower purity material may contain truncated peptides or chemical adducts that distort receptor binding kinetics and cell culture viability.
Why is endotoxin testing critical for GHRH receptor research compounds?
Bacterial endotoxins (LPS) cause inflammatory responses, cytokine release, and altered gene expression in cell cultures and animal models. High-purity peptides must undergo LAL testing to confirm endotoxin levels are below established research limits (<0.05 EU/mg).
Does Sermorelin activate the ghrelin receptor (GHSR-1a)?
No. Sermorelin is a highly selective agonist for the GHRH receptor (GHRH-R). It does not exhibit binding affinity or signal activation at the ghrelin receptor (GHSR-1a), setting it apart from GHRP-class secretagogues like Ipamorelin or GHRP-6.
How can institutional buyers verify the quality of PX1 Research Sermorelin 2000 mcg?
Every lot supplied by PX1 Research includes a lot-specific Certificate of Analysis (COA) derived from independent ISO 17025 accredited analytical laboratories, documenting RP-HPLC purity, mass spectrometry weight verification, and endotoxin content.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.